Detalhe da pesquisa
1.
A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis.
Int J Cancer
; 148(1): 238-251, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32745259
2.
Therapeutic Potential of Afatinib in NRG1 Fusion-Driven Solid Tumors: A Case Series.
Oncologist
; 26(1): 7-16, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32852072
3.
Genes and variants in hematopoiesis-related pathways are associated with gemcitabine/carboplatin-induced thrombocytopenia.
Pharmacogenomics J
; 20(2): 179-191, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31616045
4.
Erlotinib treatment induces cytochrome P450 3A activity in non-small cell lung cancer patients.
Br J Clin Pharmacol
; 85(8): 1704-1709, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30945322
5.
Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.
Int J Cancer
; 143(7): 1741-1752, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29667169
6.
Reaching the limits of prognostication in non-small cell lung cancer: an optimized biomarker panel fails to outperform clinical parameters.
Mod Pathol
; 30(7): 964-977, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28281552
7.
Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer.
BMC Cancer
; 16: 603, 2016 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27495736
8.
Lung cancer among native and foreign-born Swedes: histopathology, treatment, and survival.
Acta Oncol
; 55(11): 1344-1348, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27556916
9.
Pemetrexed and gemcitabine versus carboplatin and gemcitabine in non-small cell lung cancer: a randomized noninferiority phase II study in one center.
Oncologist
; 20(4): 365, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25732264
10.
Analysis of human papillomaviruses and human polyomaviruses in lung cancer from Swedish never-smokers.
Acta Oncol
; 59(1): 28-32, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31460811
11.
Highly elevated systemic inflammation is a strong independent predictor of early mortality in advanced non-small cell lung cancer.
Cancer Treat Res Commun
; 31: 100556, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35429913
12.
The association of four genetic variants with myelosuppression in gemcitabine-treated Japanese is not evident in gemcitabine/carboplatin-treated Swedes.
Basic Clin Pharmacol Toxicol
; 130(4): 513-521, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35132780
13.
Determination and Pharmacokinetics of Omeprazole Enantiomers in Human Plasma and Oral Fluid Utilizing Microextraction by Packed Sorbent and Liquid Chromatography-Tandem Mass Spectrometry.
Int J Anal Chem
; 2021: 8845139, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33531903
14.
Clinicopathologic Features and Response to Therapy of NRG1 Fusion-Driven Lung Cancers: The eNRGy1 Global Multicenter Registry.
J Clin Oncol
; 39(25): 2791-2802, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34077268
15.
Whole-genome sequencing and gene network modules predict gemcitabine/carboplatin-induced myelosuppression in non-small cell lung cancer patients.
NPJ Syst Biol Appl
; 6(1): 25, 2020 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32839457
16.
Genetic association of gemcitabine/carboplatin-induced leukopenia and neutropenia in non-small cell lung cancer patients using whole-exome sequencing.
Lung Cancer
; 147: 106-114, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32683206
17.
Use of narrow-range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion.
Proteomics
; 9(13): 3414-24, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19609957
18.
[Thoracal actinomycosis - a diagnostic challenge]. / Torakal aktinomykos allvarlig sjukdom och en diagnostisk svår utmaning - Men med rätt behandling är prognosen god.
Lakartidningen
; 1162019 Dec 03.
Artigo
em Sueco
| MEDLINE | ID: mdl-31821519
19.
Subjective swallowing symptoms and related risk factors in COPD.
ERJ Open Res
; 5(3)2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31579679
20.
Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11.
Lung Cancer
; 130: 50-58, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30885352